Israël – Pharmaseed to open spin-off in France

July 23, 2014 2:12 pm0 comments
Source : Google

Pharmaseed is an Israeli company specializing in translational preclinical studies for fifteen years helping universities, incubators and Israeli start-ups to translate their technological innovations in pharmaceuticals. With the expertise gained, Pharmaseed opens a spin-off in France, the 4P-Pharma laboratory. 4P-Pharma is a biotechnology company that transforms discoveries from institutes and […]

Read more ›

Israël – Vascular Biogenics sets terms for $76 million IPO

July 17, 2014 4:01 pm0 comments
Israël – Vascular Biogenics sets terms for $76 million IPO

Vascular Biogenics, a biotech developing gene therapies for certain cancers and inflammatory diseases, announced terms for its IPO on Wednesday. The Or Yehuda, Israel-based company plans to raise $76 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, […]

Read more ›

Israël – FDA accepts Teva’s NDA for albuterol MDPI

July 16, 2014 3:43 pm0 comments
Israël – FDA accepts Teva’s NDA for albuterol MDPI

Israel-based generic giant Teva Pharmaceuticals Industries (NYSE: TEVA) says that the US Food and Drug Administration has accepted for review the company’s New Drug Application for albuterol multi-dose dry-powder inhaler (MDPI). This is an investigational breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of […]

Read more ›

Israël – Chinese Fosun Pharma buys Alma Lasers for 240 million $

May 9, 2013 10:21 am0 comments
Israël – Chinese Fosun Pharma buys Alma Lasers for 240 million $

The Chinese Shanghai Fosun Pharmaceutical Group will acquire 95.6% of the shares in the Israeli group Alma Lasers specialized in solutions for cosmetic laser treatments, for  240 million $ . Alma Lasers, led by Dr. Tzvi Karmi, has a 15% share of the global market for aesthetic high-end devices with […]

Read more ›

Israël – Sun Pharma calls off $600-million plan to buyout remaining stake in Taro

February 11, 2013 8:56 pm0 comments
Israël – Sun Pharma calls off $600-million plan to buyout remaining stake in Taro

In another twist to Sun-Taro battle, the domestic drug major today called off nearly $600 million plan (over Rs. 3,100 crore) to acquire outstanding shares of Israel’s Taro Pharmaceutical citing pricing issues. The domestic pharma major also said hiking the offer price – to acquire remaining stake in Taro – would not […]

Read more ›

Recent Comments

    Tags